Behind The Breakthroughs: FDA Releases Expedited Program Data For First Time

For the more than five years of its existence, the US Food and Drug Administration’s breakthrough devices pathway has operated under a veil. While the agency has announced some breakthrough device approvals, and other breakthrough designations have been announced by the companies themselves, there’s been no single comprehensive source to show what devices are making the cut.

[